Enzyre is a startup based in the Netherlands, most recent round Series A, 4 tracked investors.
Enzyre is a company founded in 2016 headquartered in the Netherlands. Its most recent tracked round is Series A. Brouky records 4 investors associated with the company.
Enzyre develops diagnostic products for point-of-care testing. Their technology enables rapid blood coagulation analysis, providing immediate insights for critical care and thrombosis management.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.